Nuclear Factor-κB p50 Limits Inflammation and Prevents Lung Injury duringEscherichia coliPneumonia
- 1 October 2003
- journal article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 168 (7) , 810-817
- https://doi.org/10.1164/rccm.200303-412oc
Abstract
Inflammatory responses to infection must be precisely regulated to facilitate microbial killing while limiting host tissue damage. Many inflammatory genes are regulated by kappaB sites, and the p50 subunit of nuclear factor-kappaB suppresses the expression of kappaB-associated genes in vitro. We hypothesized that p50 is essential to prevent excessive inflammation and injury during infection. During pulmonary infection with Escherichia coli, the gene-targeted deficiency of p50 did not affect bacterial clearance from mouse lungs, but it resulted in increased expression of proinflammatory cytokines 6 to 24 hours after infection. This dysregulation exacerbated inflammation (neutrophil recruitment), respiratory distress (pulmonary edema and blood gas exchange impairment), and decompartmentalization (transit of protein and bacteria from the air spaces to the blood). We interpret these studies to indicate that endogenous p50 protects the host by curbing inflammatory responses to prevent injury, essential to survive pneumonia.Keywords
This publication has 50 references indexed in Scilit:
- NF-κB1/p105 Regulates Lipopolysaccharide-Stimulated MAP Kinase Signaling by Governing the Stability and Function of the Tpl2 KinasePublished by Elsevier ,2003
- Points of control in inflammationNature, 2002
- 2‐Aminoethoxydiphenyl borate (2‐APB) is a reliable blocker of store‐operated Ca2+entry but an inconsistent inhibitor of InsP3‐induced Ca2+releaseThe FASEB Journal, 2002
- The Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Phosphorylation of NF-κB p65 by PKA Stimulates Transcriptional Activity by Promoting a Novel Bivalent Interaction with the Coactivator CBP/p300Molecular Cell, 1998
- Microbiology of Hospital-Acquired PneumoniaSeminars in Respiratory and Critical Care Medicine, 1997
- Immunological defects in mice with a targeted disruption in Bcl-3.Genes & Development, 1997
- Combined Inhibition of Interleukin-1 and Tumor Necrosis Factor in Rodent Endotoxemia: Improved Survival and Organ FunctionThe Journal of Infectious Diseases, 1995
- KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells.The Journal of Experimental Medicine, 1993